Financials data is unavailable for this security.
Cash flow in CADView more
In 2023, cash reserves at Rakovina Therapeutics Inc fell by 460.52k. Cash Flow from Financing totalled 1.40m or -- of revenues. In addition the company used 1.86m for operations while cash used for investing totalled .
Cash flow per share | -0.0343 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0452 |
---|---|
Tangible book value per share | -0.0052 |
More ▼
Balance sheet in CADView more
Current ratio | 1.89 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.3609 |
---|---|
Total debt/total capital | 0.2652 |
More ▼